Skip to main content
SpringerLink
Log in

Follow Up and Recurrence

  • Chapter
  • First Online:
Lentigo Maligna Melanoma

  • 647 Accesses

Abstract

This chapter describes the unique challenges of clinical follow up of lentigo maligna (LM) and lentigo maligna melanoma (LMM), including difficulty of identifying local recurrence in a background of actinically damaged skin. The various presentations of recurrent LM/LMM are described including pigmented, nonpigmented, in situ, and invasive disease. The techniques used to assist in monitoring for recurrence such as dermoscopy and reflectance confocal microscopy are discussed. General guidelines for follow up, given a history of LM/LMM are the same as those for other types of melanoma, including at least a yearly physical/skin examination and a lymph node basin exam, with more frequent examinations for higher risk individuals, for example, those with invasive disease. As there are reports of a long latency to local recurrence (LR) in LM/LMM, greater than 3 years in several studies, long-term follow up of these patients is necessary. While the prognosis for locally recurrent LM/LMM has not been systematically studied, studies suggest that it is favorable to that of other melanoma subtypes. As the incidence of LM/LMM increases, studies of the characteristics of local recurrence are necessary to better define outcomes in this group.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McLeod M, Choudhary S, Giannakakis G, Nouri K. Surgical treatments for lentigo maligna: a review. Dermatol Surg. 2011;37(9):1210–28.

    Article  CAS  PubMed  Google Scholar 

  2. McCaul KA, Fritschi L, Baade P, Coory M. The incidence of second primary invasive melanoma in Queensland, 1982–2003. Cancer Causes Control. 2008;19(5):451–8.

    Article  PubMed  Google Scholar 

  3. Wildemore JK, Schuchter L, Mick R, Synnestvedt M, Elenitsas R, Bedrosian I, et al. Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study. Ann Plast Surg. 2001;46(5):488–94.

    Article  PubMed  Google Scholar 

  4. Etzkorn JR, Sobanko JF, Elenitsas R, Newman JG, Goldbach H, Shin TM, et al. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment. J Am Acad Dermatol. 2015;72(5):840–50.

    Article  CAS  PubMed  Google Scholar 

  5. Dong XD, Tyler D, Johnson JL, DeMatos P, Seigler HF. Analysis of prognosis and disease progression after local recurrence of melanoma. Cancer. 2000;88(5):1063–71.

    Article  CAS  PubMed  Google Scholar 

  6. Joyce KM, Joyce CW, Jones DM, Donnellan P, Hussey AJ, Regan PJ, et al. An assessment of histological margins and recurrence of melanoma in situ. Plast Reconstr Surg Glob Open. 2015;3(2), e301.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bricca GM, Brodland DG, Ren D, Zitelli JA. Cutaneous head and neck melanoma treated with Mohs micrographic surgery. J Am Acad Dermatol. 2005;52(1):92–100.

    Article  PubMed  Google Scholar 

  8. Kunishige JH, Brodland DG, Zitelli JA. Surgical margins for melanoma in situ. J Am Acad Dermatol. 2012;66(3):438–44.

    Article  PubMed  Google Scholar 

  9. Bichakjian CK, Halpern AC, Johnson TM, Foote Hood A, Grichnik JM, Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2011;65(5):1032–47.

    Article  PubMed  Google Scholar 

  10. Bohler-Sommeregger K, Schuller-Petrovic S, Knobler R, Neumann PR. Reactive lentiginous hyperpigmentation after cryosurgery for lentigo maligna. J Am Acad Dermatol. 1992;27(4):523–6.

    Article  CAS  PubMed  Google Scholar 

  11. Osborne JE, Hutchinson PE. A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision. Br J Plast Surg. 2002;55(8):611–5.

    Article  CAS  PubMed  Google Scholar 

  12. McKenna JK, Florell SR, Goldman GD, Bowen GM. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol Surg. 2006;32(4):493–504. Epub 2006/05/10.

    CAS  PubMed  Google Scholar 

  13. Powell AM, Robson AM, Russell-Jones R, Barlow RJ. Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up. Br J Dermatol. 2009;160(5):994–8.

    Article  CAS  PubMed  Google Scholar 

  14. McKenna DB, Cooper EJ, Kavanagh GM, Davie RM, McLaren KM, Tidman MJ. Amelanotic malignant melanoma following cryosurgery for atypical lentigo maligna. Clin Exp Dermatol. 2000;25(8):600–4.

    Article  CAS  PubMed  Google Scholar 

  15. Ara M, Maillo C, Martin R, Grasa MP, Carapeto FJ. Recurrent lentigo maligna as amelanotic lentigo maligna melanoma. J Eur Acad Dermatol Venereol. 2002;16(5):506–10.

    Article  CAS  PubMed  Google Scholar 

  16. Woodmansee CS, McCall MW. Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod. Dermatol Surg. 2009;35(8):1286–9.

    Article  CAS  PubMed  Google Scholar 

  17. Fisher GH, Lang PG. Treatment of melanoma in situ on sun-damaged skin with topical 5 % imiquimod cream complicated by the development of invasive disease. Arch Dermatol. 2003;139(7):945–7.

    Article  PubMed  Google Scholar 

  18. Guitera P, Haydu LE, Menzies SW, Scolyer RA, Hong A, Fogarty GB, et al. Surveillance for treatment failure of lentigo maligna with dermoscopy and in vivo confocal microscopy: new descriptors. Br J Dermatol. 2014;170(6):1305–12.

    Article  CAS  PubMed  Google Scholar 

  19. Nadiminti H, Scope A, Marghoob AA, Busam K, Nehal KS. Use of reflectance confocal microscopy to monitor response of lentigo maligna to nonsurgical treatment. Dermatol Surg. 2010;36(2):177–84.

    Article  CAS  PubMed  Google Scholar 

  20. Longo C, Moscarella E, Pepe P, Cesinaro AM, Casari A, Manfredini M, et al. Confocal microscopy of recurrent naevi and recurrent melanomas: a retrospective morphological study. Br J Dermatol. 2011;165(1):61–8. Epub 2011/03/18.

    Article  CAS  PubMed  Google Scholar 

  21. Erfan N, Kang HY, Cardot-Leccia N, Chignon-Sicard B, Passeron T, Ortonne JP, et al. Reflectance confocal microscopy for recurrent lentigo maligna. Dermatol Surg. 2011;37(10):1519–24.

    Article  CAS  PubMed  Google Scholar 

  22. Hibler BP, Connolly KL, Cordova M, Nehal KS, Rossi AM, Barker CA. Radiation therapy for synchronous basal cell carcinoma and lentigo maligna of the nose: response assessment by clinical examination and reflectance confocal microscopy. Pract Radiat Oncol. 2015;5(5):e543–7.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Paraskevas LR, Halpern AC, Marghoob AA. Utility of the Wood’s light: five cases from a pigmented lesion clinic. Br J Dermatol. 2005;152(5):1039–44.

    Article  PubMed  Google Scholar 

  24. Busam KJ, Marghoob AA, Halpern A. Melanoma diagnosis by confocal microscopy: promise and pitfalls. J Invest Dermatol. 2005;125(3):vii.

    Article  CAS  PubMed  Google Scholar 

  25. Malhotra R, Chen C, Huilgol SC, Hill DC, Selva D. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma. Ophthalmology. 2003;110(10):2011–8.

    Article  PubMed  Google Scholar 

  26. Hou JL, Reed KB, Knudson RM, Mirzoyev SA, Lohse CM, Frohm ML, et al. Five-year outcomes of wide excision and Mohs micrographic surgery for primary lentigo maligna in an academic practice cohort. Dermatol Surg. 2015;41(2):211–8.

    Article  CAS  PubMed  Google Scholar 

  27. Robinson JK. Margin control for lentigo maligna. J Am Acad Dermatol. 1994;31(1):79–85.

    Article  CAS  PubMed  Google Scholar 

  28. Connolly KL, Nijhawan R, Dusza S, Busam K, Nehal K. Time to local recurrence of lentigo maligna: implications for future studies. J Am Acad Dermatol. 2016;74(6):1247–8.

    Article  PubMed  Google Scholar 

  29. Walling HW, Scupham RK, Bean AK, Ceilley RI. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol. 2007;57(4):659–64.

    Article  PubMed  Google Scholar 

  30. Bub JL, Berg D, Slee A, Odland PB. Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up. Arch Dermatol. 2004;140(5):552–8.

    Article  PubMed  Google Scholar 

  31. de Vries K, Greveling K, Prens LM, Munte K, Koljenovic S, van Doorn MB, et al. Recurrence rate of lentigo maligna after micrographically controlled staged surgical excision. Br J Dermatol. 2016;174(3):588–93.

    Article  PubMed  Google Scholar 

  32. Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990–2000. J Invest Dermatol. 2005;125(4):685–91.

    Article  CAS  PubMed  Google Scholar 

  33. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695–706.

    Article  CAS  PubMed  Google Scholar 

  34. Pitman GH, Kopf AW, Bart RS, Casson PR. Treatment of lentigo maligna and lentigo maligna melanoma. J Dermatol Surg Oncol. 1979;5:727–37.

    Article  CAS  PubMed  Google Scholar 

  35. Hill DC, Gramp AA. Surgical treatment of lentigo maligna and lentigo maligna melanoma. Australas J Dermatol. 1999;40:25–30.

    Article  CAS  PubMed  Google Scholar 

  36. Agarwal-Antal N, Bowen GM, Gerwels JW. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J Am Acad Dermatol. 2002;47:743–8.

    Article  PubMed  Google Scholar 

  37. Huilgol SC, Selva D, Chen C, Hill DC, et al. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision. Arch Dermatol. 2004;140:1087–92.

    Article  PubMed  Google Scholar 

  38. Mahoney MH, Joseph M, Temple CL. The perimeter technique for lentigo maligna: an alternative to Mohs micrographic surgery. J Surg Oncol. 2005;91:120–5.

    Article  PubMed  Google Scholar 

  39. Jejurikar SS, Borschel GH, Johnson TM, Lowe L, et al. Immediate, optimal reconstruction of facial lentigo maligna and melanoma following total peripheral margin control. Plast Reconstr Surg. 2007;120:1249–55.

    Article  CAS  PubMed  Google Scholar 

  40. Lee MR, Ryman WJ. Treatment of lentigo maligna with total circumferential margin control using vertical and horizontal permanent sections: a retrospective study. Australas J Dermatol. 2008;49:196–201.

    Article  PubMed  Google Scholar 

  41. Abdelmalek M, Loosemore MP, Hurt MA, Hruza G. Geometric staged excision for the treatment of lentigo maligna and lentigo maligna melanoma: a long-term experience with literature review. Arch Dermatol. 2012;148:599–604.

    Article  PubMed  Google Scholar 

  42. Chirn-Lenn L, Murynka T, McKinnon JG, Arlette JP. Comparison of outcomes for malignant melanoma of the face treated using Mohs micrographic surgery and wide local excision. Dermatol Surg.: Official publication for American Society for Dermatologic Surgery [et al] 2013;39:1637–45.

    Google Scholar 

  43. Akhtar S, Bhat W, Magdum A, Stanley PR. Surgical excision margins for melanoma in situ. J Plast Reconstr Aesthet Surg: JPRAS. 2014;67:320–3.

    Article  CAS  PubMed  Google Scholar 

  44. Matos TR, Koolen PG, Ibrahim AM, Sun J, et al. Assessing Recurrence Rates Following Wide Local Excision of Head and Neck Malignant Melanoma: Immediate versus Delayed Reconstruction. Plast Reconstr Surg. 2015;135(5S):51.

    Article  Google Scholar 

  45. Rawlani R, Rawlani V, Qureshi HA, Kim J, Wayne JD. Reducing margins of wide local excision in head and neck melanoma for function and cosmesis: 5‐year local recurrence‐free survival. J Surg Oncol. 2015;111(7):795–9.

    Article  PubMed  Google Scholar 

  46. Cohen LM, McCall MW, Zax RH. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. A follow-up study. Dermatol Surg.: Official publication for American Society for Dermatologic Surgery [et al] 1998;24:673–7.

    Google Scholar 

  47. Clayton BD, Leshin B, Hitchcock MG, Marks M, et al. Utility of rush paraffin-embedded tangential sections in the management of cutaneous neoplasms. Dermatol Surg.: Official publication for American Society for Dermatologic Surgery [et al] 2000;26:671–8.

    Google Scholar 

  48. Bienert TN, Trotter MJ, Arlette JP. Treatment of cutaneous melanoma of the face by Mohs micrographic surgery. J Cutan Med Surg. 2003;7:25–30.

    Article  PubMed  Google Scholar 

  49. Bhardwaj SS, Tope WD, Lee PK. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience. Dermatol Surg.: Official publication for American Society for Dermatologic Surgery [et al] 2006;32:690–6; discussion 96–7.

    Google Scholar 

  50. Temple CL, Arlette JP. Mohs micrographic surgery in the treatment of lentigo maligna and melanoma. J Surg Oncol. 2006;94:287–92.

    Article  PubMed  Google Scholar 

  51. Bene NI, Healy C, Coldiron BM. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases. Dermatol Surg. 2008;34:660–4.

    CAS  PubMed  Google Scholar 

  52. Kunishige JH, Brodland DG, Zitelli JA. Surgical margins for melanoma in situ. J Am Acad Dermatol. 2012;66:438–44.

    Article  PubMed  Google Scholar 

  53. Newman J, Beal M, Schram SE, Lee PK. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: an update from the University of Minnesota. Dermatol Surg.: Official publication for American Society for Dermatologic Surgery [et al] 2013;39:1794–9.

    Google Scholar 

  54. De Vries K, Greveling K, Prens LM, et al. Recurrence rate of lentigo maligna after micrographically controlled staged surgical excision. Br J Dermatol. Mar;174(3):588–93.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatology Service, Memorial Sloan Kettering Cancer Center, 16 East 60th St., 4th Floor, Dermatology, New York, NY, 10022, USA

    Karen L. Connolly MD, Stephen W. Dusza DrPH, Kishwer S. Nehal MD & Erica H. Lee MD

Authors
  1. Karen L. Connolly MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen W. Dusza DrPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kishwer S. Nehal MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Erica H. Lee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karen L. Connolly MD .

Editor information

Editors and Affiliations

  1. Attending Physician, Director of Mohs and Dermatologic Surgery Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, USA

    Kishwer S. Nehal

  2. Attending Pathologist Director of Dermatopathology Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA

    Klaus J. Busam

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Connolly, K.L., Dusza, S.W., Nehal, K.S., Lee, E.H. (2017). Follow Up and Recurrence. In: Nehal, K., Busam, K. (eds) Lentigo Maligna Melanoma. Springer, Cham. https://doi.org/10.1007/978-3-319-43787-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43787-3_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43785-9

  • Online ISBN: 978-3-319-43787-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation